- Home
- GAME vs ENLV Comparison
GAME vs ENLV Comparison
Compare GAME & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- ENLV
- Stock Information
- Founded
- GAME 2011
- ENLV 2005
- Country
- GAME United States
- ENLV Israel
- Employees
- GAME N/A
- ENLV N/A
- Industry
- GAME
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- GAME
- ENLV Health Care
- Exchange
- GAME Nasdaq
- ENLV Nasdaq
- Market Cap
- GAME 27.2M
- ENLV 23.7M
- IPO Year
- GAME 2009
- ENLV 1995
- Fundamental
- Price
- GAME $0.74
- ENLV $1.21
- Analyst Decision
- GAME Strong Buy
- ENLV Strong Buy
- Analyst Count
- GAME 3
- ENLV 2
- Target Price
- GAME $3.67
- ENLV $10.00
- AVG Volume (30 Days)
- GAME 329.4K
- ENLV 83.7K
- Earning Date
- GAME 08-13-2025
- ENLV 05-30-2025
- Dividend Yield
- GAME N/A
- ENLV N/A
- EPS Growth
- GAME N/A
- ENLV N/A
- EPS
- GAME N/A
- ENLV N/A
- Revenue
- GAME $99,579,536.00
- ENLV N/A
- Revenue This Year
- GAME $6.08
- ENLV N/A
- Revenue Next Year
- GAME $21.94
- ENLV N/A
- P/E Ratio
- GAME N/A
- ENLV N/A
- Revenue Growth
- GAME 77.06
- ENLV N/A
- 52 Week Low
- GAME $0.50
- ENLV $0.81
- 52 Week High
- GAME $1.40
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- GAME 44.20
- ENLV 69.48
- Support Level
- GAME $0.72
- ENLV $0.90
- Resistance Level
- GAME $0.76
- ENLV $1.30
- Average True Range (ATR)
- GAME 0.07
- ENLV 0.08
- MACD
- GAME -0.02
- ENLV 0.03
- Stochastic Oscillator
- GAME 21.17
- ENLV 77.50
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.